UpdatesPress Release
Emcure fully acquired Gennova by buying the remaining 12.05% minority stake, making it a wholly-owned subsidiary.
Emcure Pharmaceuticals LimitedEMCURE · Filed with the exchange
This sharpens its focus on biologics and biosimilars, with Samit Mehta now leading Gennova.
The company expects no material financial impact from this consolidation.
No comments yet. Be the first.